Atlas Spine has announced the alpha launch of its True Position XL transforaminal lumbar interbody fusion (TLIF) system.
Supported by the advanced TruLIF technique, Atlas Spine says that its family of True Position XL implants ranging from 36–51mm in length exceeds current TLIF offerings and provides implants comparable to anterior lumbar interbody fusion (ALIF)/lateral footprints using a posterior approach. Utilising the TruLIF technique, surgeons and patients benefit from direct decompression, reduced cost and a minimally invasive, single incision without sacrificing implant footprint or bone graft volume.
“Surgeons finally have an L5–S1 posterior solution where lateral approaches are not an option,” states Matt Baynham, Atlas chief technical officer. “True Position’s centre pivot technology achieves what no other TLIF device on the market can do. This marks the next evolution along the True Position development continuum.”
Atlas Spine developed True Position XL in response to surgeon demands for a technology with the capability to insert significantly larger implants from a posterior approach. Leveraging the design and intraoperative success of the original True Position implant, True Position XL utilises the patented centre pivot design providing the necessary mechanical advantage for rotation, and allows surgeons to achieve optimal placement while utilising a minimally invasive approach. The TruLIF technique provides surgeons a preoperative plan and disc preparation instrumentation to maximise the implant footprint while minimising patient risk.
The first XL surgical case was completed in September 2015 by John Shiau neurological spine surgeon at Staten Island University Hospital, Staten Island, USA, using a 22mm minimally invasive portal. “Nothing on the market compares to the True Position XL footprint from a posterior approach. This should make surgeons rethink when to choose an anterior or lateral implant,” said Shiau.